Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase NA 2Phase 2 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Breast Neoplasms 3498Neoplasms 2739Prostatic Neoplasms 1583Colorectal Neoplasms 1247Lung Neoplasms 1188Motor Activity 766Head and Neck Neoplasms 621Pancreatic Neoplasms 601Colonic Neoplasms 586Uterine Cervical Neoplasms 567Carcinoma, Non-Small-Cell Lung 560Carcinoma, Hepatocellular 558Rectal Neoplasms 516Stomach Neoplasms 493Brain Neoplasms 436Anxiety Disorders 401Ovarian Neoplasms 399Pain 376Esophageal Neoplasms 347Neoplasm Metastasis 340Polycystic Ovary Syndrome 339Fatigue 324Urinary Bladder Neoplasms 314Precursor Cell Lymphoblastic Leukemia-Lymphoma 303Melanoma 298Depression 286Multiple Myeloma 283Endometrial Neoplasms 263Lymphoma 258Hematologic Neoplasms 251

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × OTHER × Advanced Malignant Solid Tumors × Clear all
NCT05749627 2025-02-27

Using Neoantigen Peptide Vaccine/neoantigen-based DC to Treat Advanced Malignant Solid Tumors

The First Affiliated Hospital of Nanchang University

Phase NA Recruiting
20 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

NCT03047811 2017-02-09

The Study of Targeted NY-ESO-1 T Cell Receptor (TCR) Genetic Modified Autologous T Cells Treatment of Advanced Solid Tumors

Fudan University

Phase NA Unknown
15 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡